Freshfields served as counsel to AeroClean Technologies, Inc. (the “Company”) on its $25 million IPO on the Nasdaq Capital Market. The Company sold 2,514,000 shares of common stock in the offering, which included the partial exercise of the underwriters’ over-allotment option and closed on November 29, 2021.

AeroClean is a pathogen elimination technology company on a mission to keep work, play and life going—with continuous air sanitization products called, Pūrgo™ (pure-go). AeroClean creates solutions for hospitals, offices and many shared spaces as well as elevators, aircraft and more. Pūrgo™ products feature SteriDuct™, a proprietary technology developed by best-in-class aerospace engineers, medical scientists and innovators. Powered by SteriDuct™, AeroClean’s solutions are medical-grade, eradicating viral, fungal and bacterial airborne pathogens. AeroClean Technologies expects to use the proceeds of the offering for supporting the build-out of its organization, funding the production of its air purification devices, establishing its consumables and services business and supporting its product development efforts for its high priority initiatives.

More details about the transaction can be found here.

The Freshfields team was led by corporate partners Valerie Ford Jacob and Michael Levitt, counsel Brian Lewis, associate Amy Fisher and corporate paralegals Claire Jang and Larissa Baker. People and reward advice was provided by partner Lori Goodman and associates Jordan Salzman and Lina Zhu. Intellectual property advice was provided by associate Danny Spencer. Tax advice was provided by partner Robert Scarborough and counsel Dennis Caracristi. The lawyers involved are all based in the New York office of the firm.

ENDS